Patents by Inventor Kevin D. Skule
Kevin D. Skule has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20080146553Abstract: Compositions including a quinolone component in an amount effective as an antibiotic when the composition is placed in a mammalian eye, and a carrier component in an amount effective to act as a carrier for the quinolone component are provided. The present compositions are substantially free of other components effective as preservatives. Preferably the quinolone component has fungistatic activity. In one very useful embodiment, the compositions include a NSAID component in an amount effective to reduce inflammation or pain when the composition is placed in a mammalian eye. Methods of using the present compositions, for example, to resolve microbial infections and/or to reduce inflammation and/or pain in a mammalian eye are included within the scope of the present invention.Type: ApplicationFiled: February 20, 2008Publication date: June 19, 2008Applicant: Allergan, Inc.Inventors: Christopher A. Muller, Elizabeth A. Bancroft, Janet K. Cheetham, Harold G. Jensen, Teresa H. Kuan, David F. Power, Kevin D. Skule
-
Publication number: 20030114464Abstract: Compositions including a quinolone component, such as ofloxacin, having fungistatic activity in the compositions, present in an amount effective as an antibiotic when the composition is placed in a mammalian eye, a NSAID component present in an amount to reduce inflammation or pain when the composition is placed in the eye, and a carrier component in an amount effective to act as a carrier for the quinolone component and NSAID component are provided. Methods of using the present compositions, for example, to resolve microbial infections and/or to reduce inflammation and/or pain in a mammalian eye are included within the scope of the present invention. Methods for treating corneal injuries are also included. In addition, methods for treating ocular infections, for example, corneal infections, are included.Type: ApplicationFiled: September 6, 2002Publication date: June 19, 2003Applicant: Allergan Sales, Inc.Inventors: Christopher A. Muller, Elizabeth A. Bancroft, Janet K. Cheetham, Harold G. Jensen, Teresa H. Kuan, David F. Power, Kevin D. Skule
-
Patent number: 6552020Abstract: Compositions including a quinolone component, such as ofloxacin, having fungistatic activity in the compositions, present in an amount effective as an antibiotic when the composition is placed in a mammalian eye, a NSAID component present in an amount to reduce inflammation or pain when the composition is placed in the eye, and a carrier component in an amount effective to act as a carrier for the quinolone component and NSAID component are provided. Methods of using the present compositions, for example, to resolve microbial infections and/or to reduce inflammation and/or pain in a mammalian eye are included within the scope of the present invention. Methods for treating corneal injuries are also included. In addition, methods for treating ocular infections, for example, corneal infections, are included.Type: GrantFiled: July 24, 2000Date of Patent: April 22, 2003Assignee: Allergan, Inc.Inventors: Christopher A. Muller, Elizabeth A. Bancroft, Janet K. Cheetham, Harold G. Jensen, Teresa H. Kuan, David F. Power, Kevin D. Skule
-
Publication number: 20030073694Abstract: Compositions including a quinolone component in an amount effective as an antibiotic when the composition is placed in a mammalian eye, and a carrier component in an amount effective to act as a carrier for the quinolone component are provided. The present compositions are substantially free of other components effective as preservatives. Preferably the quinolone component has fungistatic activity. In one very useful embodiment, the compositions include a NSAID component in an amount effective to reduce inflammation or pain when the composition is placed in a mammalian eye. Methods of using the present compositions, for example, to resolve microbial infections and/or to reduce inflammation and/or pain in a mammalian eye are included within the scope of the present invention.Type: ApplicationFiled: July 12, 2002Publication date: April 17, 2003Applicant: Allergan Sales, Inc.Inventors: Christopher A. Muller, Elizabeth A. Bancroft, Janet K. Cheetham, Harold G. Jensen, Teresa H. Kuan, David F. Power, Kevin D. Skule
-
Patent number: 6548497Abstract: Methods for reducing non-inflammatory pain caused by injuries and traumas include administering to a mammal eye having non-inflammatory pain a therapeutically effective amount of a composition comprising a quinolone component in an amount effective as an antibiotic and a NSAID component in an amount effective, in combination with the quinolone component, to provide a reduction in non-inflammatory pain.Type: GrantFiled: April 19, 2001Date of Patent: April 15, 2003Assignee: Allergan Sales, Inc.Inventors: Janet K. Cheetham, Harold G. Jensen, Christopher A. Muller, David F. Power, Kevin D. Skule
-
Patent number: 6492361Abstract: Compositions including a quinolone component in an amount effective as an antibiotic when the composition is placed in a mammalian eye, and a carrier component in an amount effective to act as a carrier for the quinolone component are provided. The present compositions are substantially free of other components effective as preservatives. Preferably the quinolone component has fungistatic activity. In one very useful embodiment, the compositions include a NSAID component in an amount effective to reduce inflammation or pain when the composition is placed in a mammalian eye. Methods of using the present compositions, for example, to resolve microbial infections and/or to reduce inflammation and/or pain in a mammalian eye are included within the scope of the present invention.Type: GrantFiled: October 5, 2000Date of Patent: December 10, 2002Assignee: Allergan Sales, IncInventors: Christopher A. Muller, Elizabeth A. Bancroft, Janet K. Cheetham, Harold G. Jensen, Teresa H. Kuan, David F. Power, Kevin D. Skule
-
Publication number: 20010034353Abstract: Methods for reducing non-inflammatory pain caused by injuries and traumas include administering to a mammal eye having non-inflammatory pain a therapeutically effective amount of a composition comprising a quinolone component in an amount effective as an antibiotic and a NSAID component in an amount effective, in combination with the quinolone component, to provide a reduction in non-inflammatory pain.Type: ApplicationFiled: April 19, 2001Publication date: October 25, 2001Applicant: Allergan Sales, Inc.,Inventors: Janet K. Cheetham, Harold G. Jensen, Christopher A. Muller, David F. Power, Kevin D. Skule
-
Patent number: 6166012Abstract: Compositions including a quinolone component in an amount effective as an antibiotic when the composition is placed in a mammalian eye, and a carrier component in an amount effective to act as a carrier for the quinolone component are provided. The present compositions are substantially free of other components effective as preservatives. Preferably the quinolone component has fungistatic activity. In one very useful embodiment, the compositions include a NSAID component in an amount effective to reduce inflammation or pain when the composition is placed in a mammalian eye. Methods of using the present compositions, for example, to resolve microbial infections and/or to reduce inflammation and/or pain in a mammalian eye are included within the scope of the present invention.Type: GrantFiled: July 30, 1999Date of Patent: December 26, 2000Assignee: Allergan Sales, Inc.Inventors: Christopher A. Muller, Elizabeth A. Bancroft, Janet K. Cheetham, Harold G. Jensen, Teresa H. Kuan, David F. Power, Kevin D. Skule